Treatment-Resistant Depression at Psych Congress 2026
4 sessions on treatment-resistant depression · September 15–19, 2026, New Orleans, LA. Compare treatment-resistant depression at other meetings →
Tuesday, September 15
Symposium · MasterClass
MasterClass: Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?
Brittany Albright · Michael Asbach
Examines glutamatergic dysfunction in MDD and the evidence for current and emerging glutamate-targeting therapies in treatment-resistant depression.
Symposium · Solving Clinical Challenges
Solving Clinical Challenges: Managing Major Depressive Disorder When First-Line Treatments Fall Short
Brittany Albright · Rebecca Barbee · Kristian Dambrino
Case-based walkthrough of evaluating apparent treatment resistance in MDD — uncovering hidden contributors like anxiety, trauma, and medical illness — and choosing among optimization, augmentation, and switching pathways.
Friday, September 18
Symposium · Interventional Psychiatry
Neuromodulation for Depression: Matching the Right Treatment to the Right Patient
Four case scenarios guide selection among TMS, ECT, VNS, theta-burst, and accelerated protocols, comparing mechanisms, indications, and sequencing within overall treatment plans.
Symposium · MDD
Modern Psychopharmacology for MDD: Switching, Sequencing, and Augmentation Strategies for Partial Responders
Mark Zimmerman · Shelley Matthews
Advanced review of switching protocols, cross-tapering, and augmentation options — lithium, T3, atypicals, dextromethorphan/bupropion, vortioxetine — for patients with incomplete antidepressant response.
Depression · Lithium & Mood Stabilizers · Novel Antidepressants
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5